US PRE-MARKET MOVERS: REGN, F, D, RAMP, UNH, BIO, NOW

In today's pre-market moves, Regeneron (REGN) is taking a significant hit after its melanoma treatment failed to meet primary endpoint criteria in a Phase 3 trial, raising concerns about its pipeline.

Newsquawk StaffPublished On the live feed at 1 more headline followed before this page went public
Newsquawk headlinesUTC

Iran has agreed to a long-term nuclear freeze instead of a complete dismantling, Al Arabiya reports citing sources/leaks. Want a long-term, multi-stage truce. Iran has withdrawn its demand for compensation, instead they are demanding economic concessions.

Merck (MRK) files to sell corporate issuance; seven-parter

US PRE-MARKET MOVERS: REGN, F, D, RAMP, UNH, BIO, NOW

Stellantis (STLAM IM) and Accenture (ACN) to start a strategic partnership to promote AI driven industrial production with Nvidia (NVDA)

Strategy (MSTR) buys 24,869 Bitcoin for USD 2.01bln during May 11-17th

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

ES -0.2% NQ -0.1% RTY -0.1%

  • REGN -11.5%: Melanoma combo fails Phase 3 primary endpoint..
  • F +5.5%: Plans to launch seven new vehicle models in Europe by 2029.
  • D +15.0%, NEE -1.7%: NEE to acquire D in all-stock deal.
  • RAMP +27.8%: Publicis agreed to buy RAMP in an all-cash $2.2B deal.
  • UNH -3.8%: BRK.B exits UNH position.
  • BIO +7.5%: Elliott builds BIO stake.
  • NOW +5.1%: BofA reinstated coverage with a 'Buy' rating and $130 PT.
Context

Conversely, Ford (F) is rallying on plans to introduce seven new vehicle models in Europe by 2029, indicative of a strong recovery strategy. The acquisition of Dominion Energy (D) by NextEra Energy (NEE) is also noteworthy; it highlights consolidation trends in the utilities sector, with likely implications for regulatory scrutiny and market dynamics.

Related headlines

The whole workspace, free to try.

Try it free